Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.607
-0.042 (-6.53%)
At close: Feb 21, 2025, 4:00 PM
0.610
+0.003 (0.43%)
After-hours: Feb 21, 2025, 7:06 PM EST

Elevation Oncology Statistics

Total Valuation

ELEV has a market cap or net worth of $35.91 million. The enterprise value is -$36.14 million.

Market Cap 35.91M
Enterprise Value -36.14M

Important Dates

The next estimated earnings date is Wednesday, March 5, 2025, before market open.

Earnings Date Mar 5, 2025
Ex-Dividend Date n/a

Share Statistics

ELEV has 59.12 million shares outstanding. The number of shares has increased by 81.44% in one year.

Current Share Class 59.12M
Shares Outstanding 59.12M
Shares Change (YoY) +81.44%
Shares Change (QoQ) +0.15%
Owned by Insiders (%) 0.27%
Owned by Institutions (%) 51.57%
Float 39.32M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.52
P/TBV Ratio 0.52
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.45.

Current Ratio 17.77
Quick Ratio 17.39
Debt / Equity 0.45
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.11

Financial Efficiency

Return on equity (ROE) is -63.67% and return on invested capital (ROIC) is -27.24%.

Return on Equity (ROE) -63.67%
Return on Assets (ROA) -25.46%
Return on Invested Capital (ROIC) -27.24%
Return on Capital Employed (ROCE) -41.85%
Revenue Per Employee n/a
Profits Per Employee -$1.45M
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ELEV has paid $43,000 in taxes.

Income Tax 43,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -78.31% in the last 52 weeks. The beta is 1.32, so ELEV's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change -78.31%
50-Day Moving Average 0.66
200-Day Moving Average 1.42
Relative Strength Index (RSI) 43.45
Average Volume (20 Days) 1,315,380

Short Selling Information

The latest short interest is 8.77 million, so 14.83% of the outstanding shares have been sold short.

Short Interest 8.77M
Short Previous Month 8.94M
Short % of Shares Out 14.83%
Short % of Float 22.30%
Short Ratio (days to cover) 2.00

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -42.01M
Pretax Income -39.66M
Net Income -41.95M
EBITDA -41.98M
EBIT -42.01M
Earnings Per Share (EPS) -$0.79
Full Income Statement

Balance Sheet

The company has $103.07 million in cash and $31.02 million in debt, giving a net cash position of $72.05 million or $1.22 per share.

Cash & Cash Equivalents 103.07M
Total Debt 31.02M
Net Cash 72.05M
Net Cash Per Share $1.22
Equity (Book Value) 69.36M
Book Value Per Share 1.17
Working Capital 99.40M
Full Balance Sheet

Cash Flow

Operating Cash Flow -38.34M
Capital Expenditures n/a
Free Cash Flow -38.34M
FCF Per Share -$0.65
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELEV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -81.44%
Shareholder Yield -81.44%
Earnings Yield -116.82%
FCF Yield -106.78%

Analyst Forecast

The average price target for ELEV is $7.20, which is 1,085.38% higher than the current price. The consensus rating is "Buy".

Price Target $7.20
Price Target Difference 1,085.38%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -33.14%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2